Gynoveda — Digital Brand Intelligence Report

Research date: 25 August 2026. Prepared from public social profiles, review platforms, search/SERP inspection, and the companion competitive-analysis.md in this workspace. TikTok is out of scope (blocked in India). Instagram and Facebook render hard login walls on public views — follower counts for those two are taken from search-result snippets and third-party trackers (Social Blade / HypeAuditor), flagged as such. Point-in-time snapshot.

1. Executive Summary

Gynoveda runs a high-visibility, founder-and-clinic-led social presence anchored by a large Instagram audience (~658K) and a deep YouTube library (78K subs, 793 videos), but its social graph is reach-heavy, reciprocation-light: a 6-figure Instagram following coexists with a 0.20% engagement rate and an almost entirely absent X/Twitter and Pinterest footprint. The single most important finding is the trust-vs-engagement asymmetry: the brand converts attention into clinical credibility far better than into conversation — a 4.7–4.8★ Google review base and 25K+ "babies conceived" claim sit on top of a social audience that barely interacts (ER ~0.2% on Instagram vs. Traya's larger following at a similar static rate, and Pee Safe's 0.19%). Overall Digital Brand Health scores 6.1/10 — a capable, well-positioned awareness-and-trust engine with an under-developed community and commerce loop. Scope: data sourced from public channels; 2 of 9 channels (X, Pinterest) had no meaningful public presence.

2. Channel Inventory

Platform	Handle / URL	Followers	Verified	Account Age	Primary Use	Active
Instagram	@gynoveda	~658K (search snippet) / ~364K (HypeAuditor Sept 2025)	✗ (not shown)	~2019	Awareness / community	Active
Instagram (2nd)	@gynoveda.wellness	103K	✗	newer	Product line spin-off	Low activity (11 posts)
Facebook	/gynoveda	not exposed (login wall)	—	~2018	Community / reviews	Active (est.)
YouTube	@Gynoveda	78K subs	✓	~2019	Education / testimonials	Active (793 videos)
LinkedIn	/company/gynoveda	23,701	✓	~2018	B2B / hiring / thought leadership	Active
X / Twitter	not found	—	—	—	—	Not found
Pinterest	pinterest.com/gynoveda	~6 pins (coupon aggregator)	—	—	Coupon reposts	Negligible
Trustpilot	trustpilot.com/review/gynoveda.com	—	—	—	Reviews	Not found (no dedicated profile surfaced)
Google Reviews	gynoveda.com / clinics	27,433 reviews (business-analysis.md)	—	—	Reviews	Active — 4.7–4.8★

Note on Instagram count: the live Google snippet reads "658K Followers, 6 Following, 785 Posts." Third-party HypeAuditor (Sept 2025) logs 364,227 followers. The ~658K figure is treated as the current point-in-time upper bound; the gap is itself a signal that follower counts are not stable and should not be read as precise. Facebook follower count is not publicly exposed behind the login wall — recorded as unavailable rather than estimated.

3. Deep-Dive by Channel

Instagram — @gynoveda

Identity

Display name: "Gynoveda." Bio: "India's Largest Ayurveda Clinic for Fertility, PCOS & Periods 🌿 25,000+ Babies Conceived Naturally · 21,000+ Google Reviews | 4.8 ⭐ · Book Appointment 👇". Link: clinic/appointment CTA. Following only 6 accounts.
Profile photo: brand wordmark/logo (consistent with YouTube and site). A second handle, @gynoveda.wellness (103K, 11 posts, "Wellness range from @gynoveda"), exists but is barely used — a partially-abandoned line extension.

Audience

Followers: ~658K (snippet) / ~364K (HypeAuditor). Following: 6. Posts: 785.
Follower growth: point-in-time snapshot; trend unavailable without time-series.
Engagement Rate: 0.20% — (avg 372 likes + 28 comments) / followers × 100, per SPEAKRJ audit (2021–2022 baseline, still the most recent public ER figure). This is well below the ~1–3.5% Instagram norm for health/wellness and signals a large but passive audience.

Content Performance

Posting frequency: high historical volume (785 posts; @gynoveda.wellness spin-off implies product-line content separation).
Content mix (by intent, inferred from bio + site): testimonial/reels ("babies conceived"), condition-education (PCOS/periods/fertility), clinic/appointment CTAs, founder/doctor credibility. Promotional share is high.
Top-performing signal: YouTube's "This Couple Overcame Unexplained Infertility After 14 Years" (1,041,416 views) is the brand's hero story format — success narratives are the engagement driver.
UGC signals: Low-to-Medium — branded hashtag presence is thin; the brand posts customer stories itself rather than surfacing a large organic UGC volume.

Commerce Integration

Bio CTA routes to clinic appointment, not directly to shop. No shoppable-product tagging evidence observed on the public bio. @gynoveda.wellness exists as a product-line handle but is under-used.

Customer Service

No public comment-thread inspection possible (login wall). DM-openness and response tone unavailable from public source.

Brand Health Signals

Sentiment: Google Reviews base (27,433 at 4.7–4.8★) is the strongest trust asset; Instagram comment sentiment not sampled (login wall).
Complaint clusters: search surfaced a consumer-complaints thread alleging "false promises, no results in 5 years, silencing negative feedback" — an isolated but reputation-relevant cluster; not corroborated at scale. Positive themes dominate Google Reviews (pregnancy/PCOS success, natural, doctor-backed).

Facebook — /gynoveda

Identity

Page "Gynoveda | Mumbai." Category: Health/Beauty. Follower count not exposed behind login wall.

Audience / Content

Linked from the site footer; the brand cites a Facebook community ("Circle of Sisterhood") as a 1.5-lakh-member asset (per business-analysis.md). Public follower count unavailable.
Engagement, posting cadence, and comment responsiveness not inspectable behind the login wall — recorded as unavailable, not estimated.

Brand Health

Facebook is referenced as the home of the private "Circle of Sisterhood" group (community playbook), but the public page's role and activity cannot be verified from public data.

YouTube — @Gynoveda

Identity

Verified. Handle @Gynoveda. 78K subscribers, 793 videos. Description: "India's #1 Ayurveda brand for Women's Health & Fertility… safe, natural, effective Ayurvedic treatments." Links: gynoveda.com + 3 more.

Audience / Content

793 videos — the deepest content library of any Gynoveda channel. Hero format: long-form customer success documentaries ("This Couple Overcame Unexplained Infertility After 14 Years" — 1,041,416 views, 1 year ago).
Content pillars: patient testimonials, doctor/clinical explainers, condition education, clinic promotion. Strong narrative/edit craft on hero videos (production value above typical D2C).
No Shorts-heavy strategy visible from the About page (Playlists: "Gynoveda Wellness," "About Gynoveda").
Engagement: view counts reach 7-figures on hero content; per-video like/comment not sampled at scale (Low confidence on ER).

Commerce / Brand Health

Descriptions carry clinic booking CTA (call 7240000700) and bit.ly clinic locator — conversion-oriented. No merch shelf observed. This channel is the brand's strongest trust-and-proof asset.

LinkedIn — /company/gynoveda

Identity

Verified company page. 23,701 followers. "World's 1st Ayurveda FemTech," founded 2018, Mumbai.

Audience / Content

B2B/hiring/thought-leadership use. Content mix: funding news, clinic expansion (Pune clinic), founder mentions, hiring. Lower volume than consumer channels.
Engagement: not sampled at scale (Low confidence).

Brand Health

Positions Gynoveda as a funded, scaling femtech (Wipro Consumer Care investment, $10M Series A) — credible B2B/employer signal.

X / Twitter — Not found

No official @gynoveda or brand handle surfaced in search or footer links (footer carries only Facebook, Instagram, YouTube). Treated as no public presence. A #Gynoveda hashtag exists (user-generated conversation) but no owned account drives it.

Pinterest — Negligible

Only coupon-aggregator repins of Gynoveda offers (~6 pins) surfaced; no owned brand board or Rich Pins. Treated as no meaningful presence.

Review Platforms

Google Reviews: 27,433 reviews at 4.7–4.8★ (business-analysis.md) — the brand's primary third-party trust signal; strong and active.
Trustpilot: No dedicated Gynoveda profile surfaced in search — recorded as not found / not actively used.
Site/store reviews: ~2,495 on the Shopify store (business-analysis.md).

4. Cross-Channel Insights

Gynoveda's social architecture is awareness-and-proof led, community-and-commerce light. Three patterns dominate:

Reach without reciprocity. A ~658K Instagram following and 78K YouTube subs sit on engagement rates near 0.2% — the brand broadcasts testimonials and condition content but has not built a two-way community loop on the open platforms (the real community lives in a private Facebook group, invisible to public analysis).
Clinic + content is the moat, not the catalog. YouTube testimonials, the "25,000+ babies conceived" bio claim, and the appointment CTA are the consistent throughline — consistent with the competitive finding that Gynoveda wins on outcome/clinical narrative, not assortment.
Channel gaps are strategic, not accidental. No X, negligible Pinterest, an under-used product-line Instagram, and no shoppable social commerce mean the social graph drives discovery and trust but routes conversion almost entirely off-platform (clinic call / website). That is defensible for a clinic-led model, but it leaves the D2C replenishment loop (the Traya subscription wedge) unaddressed on social.

5. Strategic Review

5.1 Executive Scorecard

Category	Score	Confidence
Brand Identity & Voice	8.0/10	High
Audience Quality	4.5/10	Medium
Content Strategy	7.0/10	Medium
Content Quality	7.5/10	Medium
Customer Journey Coverage	6.0/10	Medium
Trust & Reputation	8.0/10	High
Community Management	4.0/10	Low
Social Commerce Maturity	3.5/10	Medium
Competitive Positioning	6.5/10	Medium
Digital Ecosystem Consistency	8.0/10	High
Operational Maturity	6.5/10	Medium
AI Visibility	5.5/10	Low
Overall Digital Brand Health	6.1/10	weighted by confidence

Critical-floor caveat: No category scored ≤3/10, so the average is not masking a single acute crisis. However, Audience Quality (4.5/10, Medium) and Social Commerce Maturity (3.5/10, Medium) are the two structural weak points — the brand's large reach is not converting into interaction or on-platform revenue, which caps the return on its substantial content investment.

5.2 Category-by-Category Assessment

1. Brand Identity & Voice — Score: 8.0/10 (Confidence: High)

Strengths: Positioning is instantly legible everywhere — "Ayurveda Clinic for Fertility, PCOS & Periods," "25,000+ babies conceived," "no side-effects/no surgery." Consistent wordmark across Instagram, YouTube, site.
Weaknesses: Tone drifts between clinical-credible (YouTube/LinkedIn) and promotional (Instagram bio CTA); second @gynoveda.wellness handle is half-built.
Evidence: Instagram bio + YouTube @Gynoveda description + LinkedIn "world's 1st Ayurveda FemTech" + consistent logo.
Business Impact: Clear positioning lowers acquisition friction for high-intent fertility/PCOS seekers; the half-built wellness handle dilutes focus marginally.

2. Audience Quality — Score: 4.5/10 (Confidence: Medium)

Strengths: Large absolute audience (658K IG, 78K YT); real testimonial content suggests genuine customers exist.
Weaknesses: Instagram ER ~0.20% (372 avg likes / 364K–658K followers) — a passive audience disproportionate to reach. Following only 6 accounts is normal for a brand page (not a fake-follower flag), but the engagement-to-follower ratio is the authenticity concern.
Evidence: SPEAKRJ/HypeAuditor ER 0.20%; Instagram 6 following / 785 posts.
Business Impact: Paid/organic reach is buying impressions, not affinity — the audience is a billboard, not a community, which weakens word-of-mouth and referral LTV.

3. Content Strategy — Score: 7.0/10 (Confidence: Medium)

Strengths: Clear pillars — testimonials, condition education, clinical credibility, founder/doctor. Hero documentaries (1M+ view YouTube videos) are genuinely differentiated.
Weaknesses: Promotional/proof content dominates; limited lifestyle, entertainment, or UGC pillars; the second Instagram handle implies a product-line split that was never executed.
Evidence: YouTube hero video (1,041,416 views); Instagram bio CTA mix; 793-video library.
Business Impact: Strong for trust-building and consideration; thin for top-of-funnel shareability and repeat engagement outside the converted.

4. Content Quality — Score: 7.5/10 (Confidence: Medium)

Strengths: YouTube testimonials show real production value and emotional hooks; clinical explainers are credible.
Weaknesses: Inconsistent craft across the high-volume Instagram feed (no direct visual sample possible behind login wall — confidence capped at Medium).
Evidence: YouTube @Gynoveda hero content; verified channel with 793 videos.
Business Impact: Production quality supports the premium/clinical positioning; uneven IG execution is a missed consistency opportunity.

5. Customer Journey Coverage — Score: 6.0/10 (Confidence: Medium)

Strengths: Awareness (content/SEO hub, 882 URLs per competitive-analysis) and Consideration (testimonials, 4.7★ reviews) are well served. Conversion is routed via clinic CTA + website.
Weaknesses: Retention and Advocacy are under-served on open social — no subscription/replenish loop, thin UGC amplification, community locked in a private group.
Evidence: YouTube clinic CTA; Google Reviews 27,433; private "Circle of Sisterhood" group (business-analysis.md).
Business Impact: Journey is front-loaded; the brand acquires and convinces but under-monetizes retention on social — exactly where Traya's subscription model compounds LTV.

6. Trust & Reputation — Score: 8.0/10 (Confidence: High)

Strengths: 27,433 Google reviews at 4.7–4.8★; verified YouTube; funding/clinical credentials (Dr. Aarati Patil co-founder, Wipro investment).
Weaknesses: A consumer-complaints thread alleges no-results/silenced-feedback; Trustpilot not actively used (no owned profile surfaced) leaves a review-platform gap competitors may fill.
Evidence: Google Reviews 4.7–4.8★ (27,433); consumercomplaints.in thread; absence of Trustpilot profile.
Business Impact: Reputation is a top-2 brand asset; the complaint cluster is contained but the missing Trustpilot presence is a credibility blind spot for international/English-review shoppers.

7. Community Management — Score: 4.0/10 (Confidence: Low)

Strengths: A named private community ("Circle of Sisterhood," 1.5L members) exists — the strongest community asset, just not public.
Weaknesses: On open social, comment responsiveness, reply tone, and DM openness are not inspectable (Instagram/Facebook login walls); no public evidence of active two-way management.
Evidence: Private-group reference (business-analysis.md); login-walled public pages.
Business Impact: If the private group is well-moderated, real community value exists but is invisible to prospects evaluating the brand publicly — the public face reads as broadcast-only.

8. Social Commerce Maturity — Score: 3.5/10 (Confidence: Medium)

Strengths: Bio CTAs route to clinic booking; product-line Instagram handle exists.
Weaknesses: No shoppable posts, no product tagging observed, no native checkout on social, no promo-code/offer loop on social. Commerce happens on-site/clinic, not in-feed.
Evidence: Instagram bio → appointment (not shop); @gynoveda.wellness under-used; no shop-tab evidence.
Business Impact: Social drives traffic but captures zero cart value natively — leaving the recurring-revenue (subscription) opportunity entirely to the website, where Gynoveda has none (per competitive-analysis.md).

9. Competitive Positioning — Score: 6.5/10 (Confidence: Medium)

Strengths: Leads the set on YouTube depth (793 videos) and on integrated clinic+content proof; Google review volume (27,433) exceeds Traya's 7,122 store reviews and Indira's 54,796 (different platform).
Weaknesses: Trails Traya on Instagram following (685K vs ~658K) at a similar passive ER; trails Sirona (155K) / Pee Safe (231K) on Instagram too, and has no X/Pinterest where peers are at least present. Traya's subscription-driven retention is the clearest gap.
Evidence: Follower comparison table (§6); competitive-analysis.md engagement/review data.
Business Impact: Gynoveda owns the "natural fertility outcome" narrative but is out-followed and out-looped on retention by Traya and out-assorted on social commerce by the hygiene brands.

10. Digital Ecosystem Consistency — Score: 8.0/10 (Confidence: High)

Strengths: Footer links (Facebook, Instagram, YouTube) match live handles; bio CTAs align with site (clinic booking, gynoveda.com); messaging consistent across site/social ("no IVF / natural / Ayurveda").
Weaknesses: No X/Pinterest links (consistent with absence); @gynoveda.wellness handle is a loose end.
Evidence: gynoveda.com footer (FB/IG/YT); YouTube description links; consistent bio claims.
Business Impact: Coherent ecosystem reinforces trust; minimal drift.

11. Operational Maturity — Score: 6.5/10 (Confidence: Medium)

Strengths: 785 IG posts + 793 YouTube videos indicate a sustained, planned content operation; clinic-expansion news (Pune) shows campaign cadence.
Weaknesses: No visible cross-channel coordination pattern from public data; posting frequency not sampled at scale.
Evidence: Post counts (785 / 793); LinkedIn funding/clinic news cadence.
Business Impact: Content engine is real but appears siloed per-channel rather than orchestrated — a coordination upgrade would lift cumulative reach.

12. AI Visibility — Score: 5.5/10 (Confidence: Low)

Strengths: Strong entity presence — 882-URL content/SEO hub (per competitive-analysis.md), active YouTube, high Google Review volume; brand name surfaces prominently in search.
Weaknesses: Forum/discussion footprint (Reddit/Quora) not surfaced in this sweep; AI-answer entities likely pick up the brand but UGC discussion is thin.
Evidence: Content hub (competitive-analysis.md); search prominence; limited Reddit/Quora signals found.
Business Impact: Well-indexed for branded/search discovery; under-developed in peer-discussion spaces that increasingly feed AI recommendations.

5.3 Executive Synthesis

Gynoveda has built a credible, clinic-backed awareness and trust engine — a 658K Instagram following, a 793-video YouTube proof library, and a 27,433-review 4.7★ Google base — but it converts that attention into passive reach, not active community or on-platform revenue. The audience-to-engagement ratio (~0.2% ER) and the near-total absence of shoppable social commerce mean the brand's substantial content investment feeds discovery and credibility while leaking the retention and conversion layers to a website that has no subscription loop. Combined with a community that lives in a private Facebook group (invisible to public evaluation) and a missing Trustpilot presence, Gynoveda's social graph supports acquisition far better than it supports trust-at-scale or LTV — a gap Traya (subscription) and the hygiene brands (social commerce breadth) are better positioned to exploit.

5.4 Prioritized Recommendations

Launch social-native subscription / replenishment Commerce (close the 3.5/10 gap).
- Evidence: ER 0.20%; no shoppable posts, no product tagging, no subscription on-site (competitive-analysis.md).
- Action: Enable Shopify Subscriptions on program SKUs; add product-tagged Instagram/YouTube shoppable posts with a "subscribe & save" CTA; mirror Traya's 3-month auto-replenish.
- Expected impact: Captures recurring D2C revenue on social where reach already exists; directly attacks the audience-quality/commerce double weakness.

Convert the private community into public social proof.
- Evidence: "Circle of Sisterhood" 1.5L-member private group; public channels read broadcast-only (Community Mgmt 4.0/10, Low confidence).
- Action: Routinely re-share (with consent) member stories as UGC on Instagram/YouTube; run public AMAs with Dr. Patil; surface community metrics publicly.
- Expected impact: Lifts perceived community management and Audience Quality without abandoning the private group's safe space.

Open a Trustpilot + Reddit/Quora presence to defend reputation at scale.
- Evidence: 27,433 Google reviews but no surfaced Trustpilot profile; isolated consumer-complaints thread alleging suppressed feedback.
- Action: Claim/seed Trustpilot, respond to all negative reviews publicly, and fund a clinician-led Q&A presence on Reddit/Quora (also lifts AI Visibility).
- Expected impact: Closes the review-platform blind spot and pre-empts complaint-cluster narratives before they spread.

Right-size and rationalize the Instagram handle architecture.
- Evidence: @gynoveda.wellness (103K, 11 posts) is a half-built line extension; inconsistent tone between channels.
- Action: Either operationalize @gynoveda.wellness as a true product line or fold it into the main handle; standardize bio/voice.
- Expected impact: Removes a credibility loose end and concentrates engagement on one audience.

Add an X / Pinterest lightweight presence for discovery breadth.
- Evidence: No X handle; Pinterest only coupon repins; peers (Traya, Sirona, Pee Safe) have broader channel footprints.
- Action: Spin up an X account for founder/clinical thought-leadership and a Pinterest board for condition/visual content; low effort, extends top-of-funnel.
- Expected impact: Closes the platform-coverage gap vs. peers and broadens discovery without heavy production cost.

6. Competitive Benchmarking

Handles and follower snapshots for the core set named in competitive-analysis.md. Follower counts are point-in-time; ER where a public figure existed.

Platform	Gynoveda	Traya	Sirona	Pee Safe	Mylo	Himalaya Wellness
Instagram	@gynoveda (~658K)	@traya.health (685K)	@sironahygiene (155K)	@peesafe (231K)	@myloindia (est. ~200K)	@himalaya.wellness (not precisely surfaced)
Facebook	/gynoveda (count n/a)	present	/sironahygiene (53.7K likes)	/PeeSafeIndia (73.9K likes)	/myloindia	present (regional pages)
YouTube	@Gynoveda (78K, 793 vids)	@TrayaHealth (present)	@SironaHygiene (present)	channel (present)	n/a (app-led)	company channel (present)
LinkedIn	/company/gynoveda (23.7K)	/company/trayahealth (132K–204K)	present	present	present	corporate (large)
X / Twitter	Not found	@TrayaHealth (present)	present	present	present	present
Pinterest	Negligible	present	present	present	present	present (global)
Google Reviews	27,433 @ 4.7–4.8★	7,122 store (Judge.me 4.6★)	on-site live	on-site live	app store	legacy widespread

Metric	Gynoveda	Traya	Sirona	Pee Safe
Instagram ER (public fig.)	~0.20%	~0.01% (pikory) / low	not sampled	0.19% (socialveins)
Platform coverage	4/7 active	6/7	6/7	6/7
YouTube depth	793 videos	strong	moderate	moderate
Review avg (primary)	4.7–4.8★ (27,433)	4.6★ (7,122)	live/site	live/site

Key Competitive Insights:

Gynoveda leads on YouTube proof-depth and Google review volume, and owns the "natural fertility outcome" narrative none of the hygiene/OTC brands can claim.
Traya is the engagement-and-retention benchmark — larger Instagram following, a real subscription loop, and deeper LinkedIn B2B presence (132K–204K vs Gynoveda's 23.7K).
Sirona and Pee Safe out-follow Gynoveda on Instagram (155K / 231K) and run broader platform coverage (6/7 vs Gynoveda's 4/7) — they win on social ubiquity even if Gynoveda wins on clinical depth.
Clearest gap opportunity: Gynoveda's 4/7 platform coverage and ~0.2% ER vs peers' broader, more active footprints — plus the total absence of social commerce — is the opening a competitor with stronger community/commerce execution could exploit.

7. Data Sources & Confidence

Data Point	Source(s)	Confidence
Instagram @gynoveda follower count	Google search snippet (658K); HypeAuditor (364K, Sept 2025)	Medium (snippet) / Low (3rd-party)
Instagram ER 0.20%	SPEAKRJ audit (2021–2022 baseline)	Medium (dated)
YouTube 78K / 793 videos	Live YouTube About page (browser)	High
YouTube hero video 1,041,416 views	Live YouTube page	High
LinkedIn 23,701 followers	LinkedIn search snippet	High
Facebook /gynoveda presence	Site footer + Facebook URL	High (presence) / follower count Unavailable
Google Reviews 27,433 @ 4.7–4.8★	business-analysis.md (workspace)	High
Store reviews ~2,495	business-analysis.md	High
X / Pinterest absence	Search + footer inspection	Medium
Consumer-complaints thread	consumercomplaints.in search result	Low (single source)
Trustpilot not found	Search (no profile surfaced)	Medium
Competitor follower counts	Search snippets (Instagram/Twitter/LinkedIn/Facebook)	Medium
Traya IG 685K / Sirona 155K / Pee Safe 231K	Search snippets	Medium
Mylo / Himalaya IG	Mylo @myloindia confirmed; Himalaya handle not precisely surfaced	Medium / Low

Methodology Notes: Point-in-time snapshots; Instagram and Facebook render hard login walls (no dismissible modal with content behind — genuine auth gate), so follower counts there rely on search snippets and third-party trackers, not direct page inspection. Engagement rates are from the most recent public audit figures available (2021–2022 baseline for Instagram), not live calculation. Sentiment is based on a limited manual sample (Google review aggregate + one complaint thread), not a 10–20 comment per-channel sample — confidence capped accordingly. Demographics, reach, and impressions are unavailable from public sources and were omitted rather than inferred. TikTok excluded per skill scope (blocked in India).

8. Appendix A: Raw Structured Data

{
  "brandSlug": "gynoveda",
  "brandName": "Gynoveda",
  "researchDate": "2026-08-25",
  "channelsAnalyzed": ["instagram", "facebook", "youtube", "linkedin", "x", "pinterest", "google_reviews"],
  "data": {
    "brandIdentity": {
      "positioning": "Ayurveda clinic for Fertility, PCOS & Periods; 25,000+ babies conceived naturally; no IVF/surgery",
      "handles": {
        "instagram": "@gynoveda (+ @gynoveda.wellness 103K/11posts)",
        "facebook": "/gynoveda",
        "youtube": "@Gynoveda (verified)",
        "linkedin": "/company/gynoveda (verified)",
        "x": "not found",
        "pinterest": "negligible (~6 coupon repins)"
      }
    },
    "audienceDepth": {
      "instagram_followers": "658K (snippet) / 364K (HypeAuditor)",
      "instagram_following": 6,
      "instagram_posts": 785,
      "youtube_subscribers": 78000,
      "youtube_videos": 793,
      "linkedin_followers": 23701,
      "facebook_followers": "unavailable (login wall)"
    },
    "contentPerformance": {
      "instagram_ER": "0.20%",
      "youtube_hero_video_views": 1041416,
      "contentPillars": ["testimonials", "condition education", "clinical credibility", "founder/doctor", "clinic CTA"],
      "postingFrequency": "high historical volume; not sampled at scale"
    },
    "commerceIntegration": {
      "shoppablePosts": false,
      "productTagging": false,
      "bioCTA": "clinic appointment (not shop)",
      "promoCodesObserved": false
    },
    "customerService": {
      "publicCommentInspection": "not possible (login walls)",
      "dmOpen": "unavailable",
      "reviewResponseRate": "unavailable (Trustpilot absent)"
    },
    "brandHealth": {
      "googleReviews": "27,433 @ 4.7-4.8★",
      "storeReviews": 2495,
      "trustpilot": "not found",
      "complaintCluster": "1 consumer-complaints thread (no-results/silenced feedback) — isolated",
      "sentimentSample": "Limited; Google positive-dominant, one negative cluster"
    },
    "partnershipsInfluencers": {
      "ambassador": "Taapsee Pannu (per FE/competitive-analysis)",
      "ugcVolume": "Low-Medium (brand posts stories itself)"
    },
    "hiringCulture": {
      "linkedinFollowers": 23701,
      "glassdoor": "3.2/5 (57 reviews, AmbitionBox) — employee signal"
    },
    "socialSEOAuthority": {
      "indexedPages": "882-URL content hub (per competitive-analysis)",
      "entityPresence": "strong (search prominent)",
      "redditQuora": "thin"
    },
    "competitiveBenchmark": {
      "traya": {"instagram": "685K", "linkedin": "132K-204K", "youtube": "present", "er": "low"},
      "sirona": {"instagram": "155K", "facebook": "53.7K likes", "youtube": "present"},
      "peesafe": {"instagram": "231K", "facebook": "73.9K likes", "er": "0.19%"},
      "mylo": {"instagram": "@myloindia", "facebook": "@myloindia", "model": "app-led"},
      "himalaya": {"instagram": "@himalaya.wellness (not precisely surfaced)", "platforms": "broad global"}
    }
  },
  "strategicReview": {
    "brandIdentity": {"score": 8.0, "confidence": "High"},
    "audienceQuality": {"score": 4.5, "confidence": "Medium"},
    "contentStrategy": {"score": 7.0, "confidence": "Medium"},
    "contentQuality": {"score": 7.5, "confidence": "Medium"},
    "customerJourneyCoverage": {"score": 6.0, "confidence": "Medium"},
    "trustReputation": {"score": 8.0, "confidence": "High"},
    "communityManagement": {"score": 4.0, "confidence": "Low"},
    "socialCommerce": {"score": 3.5, "confidence": "Medium"},
    "competitivePositioning": {"score": 6.5, "confidence": "Medium"},
    "digitalEcosystem": {"score": 8.0, "confidence": "High"},
    "operationalMaturity": {"score": 6.5, "confidence": "Medium"},
    "aiVisibility": {"score": 5.5, "confidence": "Low"},
    "overallDigitalBrandHealth": 6.1
  },
  "dataConfidence": {
    "instagramFollowers": "Medium",
    "instagramER": "Medium (dated baseline)",
    "facebookFollowers": "Unavailable",
    "competitorCounts": "Medium"
  },
  "methodologyNotes": "Login walls on Instagram/Facebook prevented direct inspection; counts from snippets/third-party. ER from 2021-2022 public audit. TikTok out of scope (India block). Sentiment sample limited."
}

</details>

9. Appendix B: Research Log

Channels attempted: Instagram, Facebook, YouTube, LinkedIn, X, Pinterest, Google Reviews, Trustpilot. Methods used:

Web search for handle enumeration + follower snippets (Instagram, YouTube, LinkedIn, competitors).
browser_navigate + snapshot on YouTube About (confirmed 78K / 793 videos) and Instagram/Facebook (both hard login walls — no dismissible modal with content behind; recorded as genuine auth gates, not "closed modal").
terminal curl of gynoveda.com footer — confirmed only Facebook, Instagram, YouTube links (no X/Pinterest).
Search sweeps for complaints/reviews (consumercomplaints.in, AmbitionBox, Google Reviews aggregate).

Blockers encountered:

Instagram & Facebook — hard login walls; follower counts from search snippets (658K IG) and HypeAuditor (364K). Facebook follower count unobtainable; recorded Unavailable.
Instagram engagement rate — only a 2021–2022 SPEAKRJ baseline (0.20%) publicly available; no live calculation possible.
X / Pinterest — no owned Gynoveda presence found; excluded from active-channel scoring.
Trustpilot — no dedicated profile surfaced; treated as not actively used.
Sentiment — limited to Google review aggregate + one complaint thread; below the 10–20 per-channel comment target, so Community Management and AI Visibility confidence capped at Low.

Quietcom

Digital Brand Intelligence

Gynoveda — Digital Brand Intelligence Report

1. Executive Summary

2. Channel Inventory

3. Deep-Dive by Channel

Instagram — @gynoveda

Facebook — /gynoveda

YouTube — @Gynoveda

LinkedIn — /company/gynoveda

X / Twitter — Not found

Pinterest — Negligible

Review Platforms

4. Cross-Channel Insights

5. Strategic Review

5.1 Executive Scorecard

5.2 Category-by-Category Assessment

5.3 Executive Synthesis

5.4 Prioritized Recommendations

6. Competitive Benchmarking

7. Data Sources & Confidence

8. Appendix A: Raw Structured Data

9. Appendix B: Research Log